Task order award for "non-clinical safety assessment of PTH-RM/L Y2561553 to support hyperparathyroidism indication" to lovelace biomedical and environmental research institute
Ended Awarded Last action
- Contract number
- HHSN27100001
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $80,107
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $80,107.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,326,659 | |
| Original award | $2,406,766 |
About this award
This is a task order award under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" indefinite delivery, indefinite quantity (IDIQ) contract, issued by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The $80,107.22 award to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) is for non-clinical safety assessment of a compound (PTH-RM/L Y2561553) to support its development for a hyperparathyroidism indication. LBERI is a not-for-profit contract research organization that provides preclinical research services, including animal studies, to government agencies like NIH. This task order does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN27100001?
HHSN27100001 was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 8, 2017.
How much is contract HHSN27100001 worth?
The government has obligated $80,107 on HHSN27100001.
Which agency awarded contract HHSN27100001?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract HHSN27100001 an order under another contract?
Yes. HHSN27100001 is a delivery order under HHSN271201700017I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract HHSN27100001 competed?
The extent of competition for HHSN27100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award